Gotham Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.76M Sell
37,820
-3,052
-7% -$398K 0.01% 942
2025
Q4
$4.97M Buy
40,872
+32,635
+396% +$4.1M 0.02% 815
2025
Q3
$924K Buy
8,237
+5,078
+161% +$594K ﹤0.01% 1221
2025
Q2
$423K Buy
+3,159
New +$347K ﹤0.01% 1374
2024
Q3
Sell
-1,993
Closed -$300K 1523
2024
Q2
$300K Buy
+1,993
New +$239K ﹤0.01% 1225
2023
Q3
Sell
-18,727
Closed -$1.57M 1410
2023
Q2
$1.57M Sell
18,727
-10,532
-36% -$806K 0.03% 622
2023
Q1
$2.22M Buy
29,259
+12,242
+72% +$847K 0.05% 482
2022
Q4
$1.05M Buy
+17,017
New +$905K 0.03% 659

Other funds holding TMDX

Gotham Asset Management's TMDX Position: Q1 2026 in Review

Gotham Asset Management reduced its Transmedics (TMDX) stake by 7.5% in Q1 2026, selling an estimated $398K and leaving 37,820 shares worth $3.76M. The position accounts for 0.01% of the portfolio, ranked #942.

Gotham Asset Management first reported a position in TMDX in Q4 2022 and has held it in 8 quarters since. The position peaked at $4.97M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Gotham Asset Management held 37,820 shares of Transmedics worth $3.76M as of Q1 2026.
  • Gotham Asset Management sold 3,052 Transmedics shares in Q1 2026, an estimated $398K.
  • Transmedics made up 0.01% of Gotham Asset Management's portfolio in Q1 2026, its #942 holding.
  • Gotham Asset Management first reported a position in Transmedics in Q4 2022 and has held it in 8 quarters since.
  • Gotham Asset Management's Transmedics position peaked at $4.97M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.